Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bangkok Metropolitan Administration Medical College and Vajira Hospital
The investigators measured anti-SARS-CoV-2 antispike RBD IgG and neutralizing antibody by surrogate virus neutralizing test (sVNT) in adults between age 18-72 year after first dose of ChAd0x1 nCoV-19 vaccine.The primary outcome was the antibody levels.The secondary outcome were adverse events,factors affecting antibody levels and incidence of COVID-19 infection at the time of study
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may not be if
Allergic to components of vaccine
Risk of COVID-19 infection in the previous 14 days before enrollment i.e close contact with index cases or history of fever with upper respiratory tract infection.
